Metadata from OpenAlexLast checked: Jun 8, 2026

Journal of Neuro-Oncology — Journal Profile & Submission Links

Springer · ISSN-L 0167-594X

Journal of Neuro-Oncology publishes articles in oncology.

Listed metrics: Q2, OpenAlex 2-year citedness 2.52.

Authors checking fit can use the scope note and the official links on this profile.

→ Check whether your manuscript fits this journal, free

This page provides a source-backed journal profile and links to official submission resources. Journal instructions can change. Always verify article types, formatting, fees, ethics requirements, and submission rules on the official journal website before submitting.

Official links

Publisher
Springer
Publisher country
Netherlands
Open access
No
APC (USD)
3,190 EUR
Works count
9523
Cited-by count
304799
OpenAlex 2-year mean citedness
2.52
Quartile
Q2

The journal's own scope statement

The text below is the catalog scope statement for this journal.

Research topics: Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Meningioma and schwannoma management, Neurofibromatosis and Schwannoma Cases, Neuroblastoma Research and Treatments, Lung Cancer Research Studies, Pituitary Gland Disorders and Treatments, Management of metastatic bone disease

Catalog source: merged. This is not a copy of the publisher's author instructions.

Submission & timeline

General pre-submission checks for medical manuscripts

Generic checklist only — not journal-specific requirements.

  • Confirm scope fit and intended article type on the official journal site.
  • Abstract structure matches the journal's current requirements.
  • Ethics approval and trial registration statements are complete.
  • Informed consent and patient privacy statements are in place.
  • Reporting guideline compliance (e.g. CONSORT, STROBE, PRISMA) as applicable.
  • Reference style and citation limits per official guidelines.
  • Figures and tables meet resolution, labeling, and count limits.
  • Cover letter addresses novelty, fit, and required declarations.
  • Conflicts of interest statement included.
  • Funding statement included.
  • Data availability statement included when required.

FAQ